Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water.

scientific article published on 13 November 2017

Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/OEMED-2017-104651
P932PMC publication ID5749314
P698PubMed publication ID29133598

P50authorChristian H. LindhQ42918326
Daniel MucsQ63378323
P2093author name stringYing Li
Kristina Jakobsson
Tony Fletcher
Kristin Scott
Pia Tallving
P2860cites workRate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West VirginiaQ24633826
Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, GermanyQ34116656
Perfluoroalkyl acids: a review of monitoring and toxicological findingsQ34630884
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workersQ34680365
Tracking the pathways of human exposure to perfluorocarboxylates.Q35001255
Drug transport by Organic Anion Transporters (OATs).Q38030260
Perfluorooctane sulfonate: a review of human exposure, biomonitoring and the environmental forensics utility of its chirality and isomer distributionQ38366490
Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed communityQ38711850
Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life.Q39360818
Human detoxification of perfluorinated compoundsQ42973627
Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK modelQ44550012
A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humansQ46212335
Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-livesQ48431394
Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010.Q50511791
Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations.Q51794582
Contribution of Direct and Indirect Exposure to Human Serum Concentrations of Perfluorooctanoic Acid in an Occupationally Exposed Group of Ski Waxers.Q53080615
Differences in the isomer composition of perfluoroctanesulfonyl (PFOS) derivativesQ79964917
Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modelingQ88107216
P433issue1
P921main subjectdrinking waterQ7892
P304page(s)46-51
P577publication date2017-11-13
P1433published inOccupational and Environmental MedicineQ7075795
P1476titleHalf-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water
P478volume75

Reverse relations

cites work (P2860)
Q92673149Adverse Maternal, Fetal, and Postnatal Effects of Hexafluoropropylene Oxide Dimer Acid (GenX) from Oral Gestational Exposure in Sprague-Dawley Rats
Q90113647Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances
Q90310069Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water
Q99613125Chemical Characterization of a Legacy Aqueous Film-Forming Foam Sample and Developmental Toxicity in Zebrafish (Danio rerio)
Q62387081Childhood perfluoroalkyl substance exposure and executive function in children at 8 years
Q94567957Concentration of selected liver enzymes across the stages of glomerular function: the associations with PFOA and PFOS
Q93123912Derivation of a chronic reference dose for perfluorohexane sulfonate (PFHxS) for reproductive toxicity in mice
Q89836896Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial
Q91832552Dynamics of PCB exposure in the past 50 years and recent high concentrations in human breast milk: Analysis of influencing factors using a physiologically based pharmacokinetic model
Q93000711Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women
Q90362060Endocrine Disruptors in Water and Their Effects on the Reproductive System
Q95836430Estimating Environmental Hazard and Risks from Exposure to Per- and Polyfluoroalkyl Substances (PFAS): Outcome of a SETAC Focused Topic Meeting
Q60126454Evaluation and Management Strategies for Per- and Polyfluoroalkyl Substances (PFASs) in Drinking Water Aquifers: Perspectives from Impacted U.S. Northeast Communities
Q89349832Exposure to perfluoroalkyl substances and associations with serum thyroid hormones in a remote population of Alaska Natives
Q91948873Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria
Q90356625Intrauterine exposure to perfluorinated compounds and overweight at age 4: A case-control study
Q91961959Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight
Q59156231Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study)
Q49599814Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study
Q93350965Per and polyfluoroalkyl substances (PFAS) blood levels after contamination of a community water supply and comparison with 2013-2014 NHANES
Q100444139Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
Q89134221Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model
Q64072217Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation
Q59800731Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes
Q99592078Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults
Q90633512Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) acutely affect human α1β2γ2L GABAA receptor and spontaneous neuronal network function in vitro
Q97526919Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function
Q62387101Prenatal and childhood exposure to perfluoroalkyl substances (PFAS) and measures of attention, impulse control, and visual spatial abilities
Q64128838Prenatal and childhood exposure to poly- and perfluoroalkyl substances (PFAS) and cognitive development in children at age 8 years
Q98729995Recent US State and Federal Drinking Water Guidelines for Per- And Polyfluoroalkyl Substances (PFAS)
Q93160224Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota
Q62086877Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food
Q58701478Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy
Q97556479Serum Half-Lives for Short- and Long-Chain Perfluoroalkyl Acids after Ceasing Exposure from Drinking Water Contaminated by Firefighting Foam
Q89754498Serum Levels of Perfluoroalkyl Substances (PFAS) in Adolescents and Young Adults Exposed to Contaminated Drinking Water in the Veneto Region, Italy: A Cross-Sectional Study Based on a Health Surveillance Program
Q92109687Toxicokinetics of perfluorobutane sulfonate (PFBS), perfluorohexane-1-sulphonic acid (PFHxS), and perfluorooctane sulfonic acid (PFOS) in male and female Hsd:Sprague Dawley SD rats after intravenous and gavage administration

Search more.